Yu, Jia
Qin, Bo
Moyer, Ann M.
Sinnwell, Jason P.
Thompson, Kevin J.
Copland, John A. III
Marlow, Laura A.
Miller, James L.
Yin, Ping
Gao, Bowen
Minter-Dykhouse, Katherine
Tang, Xiaojia
McLaughlin, Sarah A.
Moreno-Aspitia, Alvaro
Schweitzer, Anthony
Lu, Yan
Hubbard, Jason
Northfelt, Donald W.
Gray, Richard J.
Hunt, Katie
Conners, Amy L.
Suman, Vera J.
Kalari, Krishna R.
Ingle, James N.
Lou, Zhenkun
Visscher, Daniel W.
Weinshilboum, Richard
Boughey, Judy C.
Goetz, Matthew P.
Wang, Liewei
Funding for this research was provided by:
Mayo Clinic Center for Individualized Medicine
Pharmacogenomics Research Network (U19 GM61388-15)
National Institutes of Health (National Institutes of Healt)
Mayo Clinic Cancer Center (CA15083-40A2)
Mayo Clinic Breast Specialized Program of Research Excellence (P50CA116201)
John P. Guider
Article History
Received: 10 January 2017
Accepted: 15 November 2017
First Online: 6 December 2017
Change Date: 25 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13058-021-01420-z
Ethics approval and consent to participate
: The study received ethical approval from the Mayo Clinic Institutional Review Board. All patients who participated in this study provided written informed consent. The Mayo Clinic Institutional Animal Care and Use Committee reviewed and approved all of the mouse experiments.
: All patients who participated in this study provided written informed consent for data publishing.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.